Quick Heal Technologies (BOM:539678) Research & Development: ₹0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539678 Quick Heal Technologies Ltd BOM:539678
65 GF Score
Price ₹153.65
GF Value ₹314.69
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Quick Heal Technologies Research & Development?

Quick Heal Technologies BOM:539678 -0.55% 65 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:539678 with a GF Score™ of 65/100 and a GF Value™ of ₹314.69 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Quick Heal Technologies's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Quick Heal Technologies  (BOM:539678) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Quick Heal Technologies Research & Development Related Terms

Quick Heal Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Quick Heal Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quick Heal Technologies Research & Development Chart

Quick Heal Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Quick Heal Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:539678
65GF Score
Quick Heal Technologies Ltd BOM:539678
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quick Heal Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Quick Heal Technologies (BOM:539678) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Quick Heal Technologies and its competitors.
Is Quick Heal Technologies' Research & Development too high?
Quick Heal Technologies' current Research & Development is ₹0 Mil. Overall, Quick Heal Technologies has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Quick Heal Technologies' Research & Development compare to UBER and SHOP?
Quick Heal Technologies' Research & Development of ₹0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Quick Heal Technologies and its competitors. Quick Heal Technologies's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quick Heal Technologies stock overvalued right now?
Based on GuruFocus' analysis, Quick Heal Technologies (BOM:539678) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹314.69, compared to a current price of ₹153.65 — trading 51.2% below its estimated fair value. The current Research & Development is ₹0 Mil. Quick Heal Technologies' overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Quick Heal Technologies (BOM:539678), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Quick Heal Technologies (BOM:539678) Overvalued in 2026?

Based on GuruFocus' analysis, Quick Heal Technologies stock appears to be undervalued. The current stock price of ₹153.65 is trading 51.2% below its estimated GF Value™ of ₹314.69. GuruFocus considers Quick Heal Technologies to be Significantly Undervalued.

Key valuation signals for BOM:539678:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹314.69 vs. price of ₹153.65 (51.2% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the BOM:539678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quick Heal Technologies Business Description

Other Exchanges QUICKHEAL:India
Address Viman Nagar, Office No. 7010 C & D, 7th Floor, Solitaire Business Hub, Pune, MH, IND, 411014
Quick Heal Technologies Ltd is an India-based IT security solutions company. It is engaged in offering software security products and solutions. The company serves clients in various industries including manufacturing, BFSI, healthcare, hospitality, educational institutions, government organizations, emerging e-commerce, and the service sector. The group reports the operating segments based on the target customer groups are; Consumer, and Enterprise and Government. It has a business presence in India and foreign countries, of which maximum revenue is derived within India. Its product range consists of Quick Heal Total Security, Quick Heal Internet Security, Quick Heal AntiVirus Pro, Quick Heal Total Security for Mac, Quick Heal PCTuner 3.0, and Guardian NetSecure.
65GF Score

Get the complete analysis for BOM:539678

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹153.65
Price
₹314.69
GF Value